Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 435 | 253 | 168 | 176 | 431 |
| Cost of Goods | 79 | 113 | 87 | 64 | 404 |
| Gross Profit | 355 | 140 | 81 | 113 | 27 |
| Operating Expenses | 3,508 | 9,579 | 2,243 | 1,913 | 2,419 |
| Operating Income | -3,073 | -9,326 | -2,075 | -1,736 | -1,988 |
| Interest Expense | 14 | 2 | 1 | 1 | 1 |
| Other Income | 8 | 2 | 2 | 147 | 0 |
| Pre-tax Income | -3,079 | -9,325 | -2,074 | -1,590 | -1,989 |
| Net Income Continuous | -3,079 | -9,325 | -2,074 | -1,590 | -1,989 |
| Net Income | $-3,079 | $-9,325 | $-2,074 | $-1,590 | $-1,989 |
| EPS Basic Total Ops | -1,438.56 | -6,113.90 | -1,438.56 | -1,078.92 | 2,517.49 |
| EPS Basic Continuous Ops | -1,548.20 | -6,094.50 | -1,356.10 | -1,041.48 | 2,478.69 |
| EPS Diluted Total Ops | -1,438.56 | -6,113.90 | -1,438.56 | -1,078.92 | 2,517.49 |
| EPS Diluted Continuous Ops | -1,548.20 | -6,094.50 | -1,356.10 | -1,041.48 | 2,478.69 |
| EBITDA(a) | $-3,061 | $-9,304 | $-2,054 | $-1,715 | $-1,969 |